Peel Hunt Reaffirms “Buy” Rating for Udg Healthcare (LON:UDG)

Peel Hunt restated their buy rating on shares of Udg Healthcare (LON:UDG) in a research note published on Thursday, ThisIsMoney.Co.Uk reports.

A number of other research firms also recently issued reports on UDG. Berenberg Bank lifted their price target on shares of Udg Healthcare from GBX 700 ($9.15) to GBX 850 ($11.11) and gave the company a hold rating in a research report on Tuesday, August 20th. Royal Bank of Canada cut Udg Healthcare to a sector performer rating and lowered their price target for the stock from GBX 830 ($10.85) to GBX 800 ($10.45) in a report on Monday, August 12th. Liberum Capital reaffirmed a buy rating on shares of Udg Healthcare in a research note on Tuesday, November 26th. Finally, Barclays reaffirmed an overweight rating and set a GBX 830 ($10.85) price objective on shares of Udg Healthcare in a report on Thursday, November 21st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Udg Healthcare presently has a consensus rating of Hold and a consensus target price of GBX 858.17 ($11.21).

Shares of UDG opened at GBX 805 ($10.52) on Thursday. Udg Healthcare has a twelve month low of GBX 545 ($7.12) and a twelve month high of GBX 846 ($11.05). The company has a current ratio of 1.59, a quick ratio of 1.50 and a debt-to-equity ratio of 26.65. The firm has a market capitalization of $2.01 billion and a P/E ratio of 35.15. The firm’s 50-day moving average is GBX 780.40 and its two-hundred day moving average is GBX 762.21.

The firm also recently disclosed a dividend, which will be paid on Wednesday, February 5th. Investors of record on Thursday, January 9th will be given a $0.12 dividend. The ex-dividend date is Thursday, January 9th. This is a positive change from Udg Healthcare’s previous dividend of $0.04. This represents a dividend yield of 1.28%. Udg Healthcare’s payout ratio is currently 0.57%.

About Udg Healthcare

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.

See Also: What is the float in trading stocks?

Analyst Recommendations for Udg Healthcare (LON:UDG)

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with's FREE daily email newsletter.